
COVID Driven Omicron Wave Saw A Surge In Younger Patients, Deaths Due To Co-Morbidities: ICMR
- byDoctor News Daily Team
- 18 February, 2025
- 0 Comments
- 0 Mins

New Delhi: Indian Council of Medical Research chief Dr. Balram Bhargava stated that third COVID wave surge in India saw younger population as patients with lesser proportions of all symptoms and higher level of co-morbidities. Also, that 10 per cent of the deaths due to the Omicron variant had happened in vaccinated people who ended up in hospitals, as compared with 22 per cent in those who were not vaccinated against COVID.
About 91 percent of those vaccinated who died due to infection had co-morbidities, against 83 percent of those unvaccinated who succumbed to the infectious disease.
The mean age of the younger hospitalized population during this third wave was about 44 years, he said, but added that the incident of co-morbidities was higher in this group, at close to half (46 per cent).
Also Read:Health ministry cuts use of steroids, multivitamins, remdesivir, tocilizumab in new COVID-19 treatment guidelines
According to the data collected of hospitalized people in 37 different hospitals across India which did the plasma study during the first and second surge and which are part of the National COVID Clinical Registry, the Omicron surge saw younger in-patients of 44 years as opposed to 55 years earlier, whereas a comparison of co-morbidities stood at 46 per cent versus the 66 per cent earlier. The study also found the common symptoms, mainly sore throat, lesser use of drugs, and significantly improved outcomes.
These results stressed that vaccines may be largely protecting people from severe COVID and deaths, said Dr. Bhargava.
The comparative study was conducted in two different time frame from November 15 to December 16, when Delta was the predominant variant and between December 16 to January 17, when Omicron variant was. These included 564 hospitalized due to Delta and 956 hospitalized due to Omicron.
Also Read:ICMR nominates Kerala Hospital as Advanced Centre for Clinical Trials
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.

Recent News
Normal-Tension Glaucoma Closely Associated With Co...
- 10 October, 2022
Air Pollution Tied To Increased Risk Of Premature...
- 24 May, 2023

Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!